Literature DB >> 17518595

Properties of the human umbilical vein as a living scaffold for a tissue-engineered vessel graft.

Markus Hoenicka1, Karla Lehle, Volker R Jacobs, Franz X Schmid, Dietrich E Birnbaum.   

Abstract

Umbilical cords are usually discarded after delivery, even though they contain a set of functional vessels. We investigated whether the human umbilical vein (HUV) is suitable as a storable scaffold for the tissue engineering of small-caliber vessel grafts. Isolated HUVs were cryopreserved by freezing or vitrification. The reaction of the vessels to vasoactive compounds and the mechanical properties were determined in an organ bath. Mitochondrial metabolism, release of antithrombotic compounds, and platelet adhesion were measured on the luminal vessel surface. Seeding with endothelial cells was tested on denuded HUVs. The vessels showed a weak response to norepinephrine but were readily contracted by serotonin and by the thromboxane A2 mimetic U46619. Endothelium-dependent vasorelaxation was weak, reaching significance only for histamine. However, the vessels relaxed to sodium nitroprusside, and to acetylcholine if sandwiched with human saphenous vein. Cryopreservation did not change the mechanical properties in the relevant tension range. Vasoconstriction to potassium chloride and serotonin were reduced after freezing (22.9+/-7.6%, 27.7+/-10.2%) and after vitrification (2.6+/-5.8%, 4.3+/-7.1%). The mitochondrial metabolism was also attenuated after freezing (57.9+/-25.9%) and after vitrification (21.7+/-6.7%). Prostacyclin release was elevated after both cryopreservation procedures (4.0-fold, 3.9-fold), whereas there was no significant change in the adhesion of platelets. Denuded HUVs could readily be seeded with isolated endothelial cells before and after freezing. We conclude that HUV is suitable as a storable living scaffold with antithrombogenic properties.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17518595     DOI: 10.1089/ten.2006.0121

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  8 in total

1.  Selective venous vasodilator properties of the analgesic metamizole (dipyrone) in a human ex vivo model-implications for postoperative pain management.

Authors:  Markus Hoenicka; Hagen Gorki; Karl Traeger; Andreas Liebold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-31       Impact factor: 3.000

2.  Removal of an abluminal lining improves decellularization of human umbilical arteries.

Authors:  Ho-Yi Tuan-Mu; Yi-Hao Chang; Jin-Jia Hu
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

3.  Cryopreservation of vascular tissues.

Authors:  Else Müller-Schweinitzer
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

4.  Development of a mechanically tuneable 3D scaffold for vascular reconstruction.

Authors:  Maritza Rodriguez; Cassandra Juran; Mark McClendon; Cyril Eyadiel; Peter S McFetridge
Journal:  J Biomed Mater Res A       Date:  2012-07-24       Impact factor: 4.396

5.  Physiologically Modeled Pulse Dynamics to Improve Function in In Vitro-Endothelialized Small-Diameter Vascular Grafts.

Authors:  Joseph S Uzarski; Jhon Cores; Peter S McFetridge
Journal:  Tissue Eng Part C Methods       Date:  2015-06-24       Impact factor: 3.056

6.  Challenges in translating vascular tissue engineering to the pediatric clinic.

Authors:  Daniel R Duncan; Christopher K Breuer
Journal:  Vasc Cell       Date:  2011-10-14

Review 7.  Current advances in the translation of vascular tissue engineering to the treatment of pediatric congenital heart disease.

Authors:  Ethan W Dean; Brooks Udelsman; Christopher K Breuer
Journal:  Yale J Biol Med       Date:  2012-06-25

Review 8.  Umbilical cord tissue cryopreservation: a short review.

Authors:  Irina Arutyunyan; Timur Fatkhudinov; Gennady Sukhikh
Journal:  Stem Cell Res Ther       Date:  2018-09-15       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.